Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
Subject matter: A decision taken by the European Chemicals Agency pursuant to Article 46(1) of the REACH Regulation
Contested Decision: Decision of 12 March 2021 on the substance evaluation of resorcinol (EC No 203-585-2; CAS No 108-46-3)
Remedy sought by the Appellant
By the Contested Decision, the Agency required the registrants of resorcinol to submit information on a larval amphibian growth and development assay (‘LAGDA’) according to OECD test guideline 241.
A first substance evaluation of resorcinol took place in 2017. At that time, the evaluating Member State competent authority considered that performing a LAGDA would not provide relevant new information on the endocrine disrupting properties of resorcinol. The Contested Decision was adopted following a second substance evaluation of resorcinol conducted by another evaluating Member State competent authority.
CONTINUE READING ON: echa.europa.eu2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions